Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bone cancer, Sarcoma
Closed
Phase 2
This trial is looking at a drug called mifamurtide for a type of bone cancer called osteosarcoma. It is for people who have osteosarcoma that has come back after treatment and cannot be completely removed with surgery (advanced osteosarcoma).
Recruitment start: 31 October 2014
Recruitment end: 29 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor A B Hassan
European Union
Experimental Cancer Medicine Centre (ECMC)
Millennium Pharmaceuticals Inc
NIHR Clinical Research Network: Cancer
University of Oxford
Last reviewed: 29 June 2016
CRUK internal database number: 12089